| First Author | Stern MC | Year | 1997 |
| Journal | Mol Carcinog | Volume | 20 |
| Issue | 1 | Pages | 137-42 |
| PubMed ID | 9328444 | Mgi Jnum | J:43950 |
| Mgi Id | MGI:1099172 | Doi | 10.1002/(sici)1098-2744(199709)20:1<137::aid-mc15>3.0.co;2-2 |
| Citation | Stern MC, et al. (1997) Increased apoptosis during papilloma development in mice susceptible to tumor progression. Mol Carcinog 20(1):137-42 |
| abstractText | Programmed cell death (apoptosis) is known to occur not only during normal development and tissue remodeling but also during neoplasia. Despite the suggested role of apoptosis in preventing the proliferation of malignant cells, a positive correlation between tumor progression and the presence of apoptotic cells has been found in different types of cancer, including epithelial tumors. In normal mouse skin, the role of apoptosis is not completely understood, and it has been suggested that terminal differentiation may be a special case of apoptosis. In the work reported here, we counted apoptotic cells in mouse skin tumors generated with a two-stage chemical carcinogenesis protocol. We analyzed papillomas from outbred SENCAR mice at different times during promotion, and to better determine the correlation between apoptosis and tumor progression, we compared papillomas generated from two inbred strains derived from the SENCAR stock that differ in their susceptibility to tumor progression. Our results showed that in mouse skin chemical carcinogenesis, the number of apoptotic cells was greater in papillomas that may have been in the process of progressing to squamous cell carcinomas. This conclusion is also supported by the fact that papillomas from SENCAR P/Bt. mice, a tumor progression-susceptible strain derived from outbred SENCAR mice, had more apoptotic cells than papillomas from progression-resistant SSIN mice. |
